Zepp Health (FRA:ST0) ROE %: -38.71% (As of Mar. 2026)


FRA:ST0 Zepp Health Corp FRA:ST0
40 GF Score
Price €3.70
GF Value €3.24
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Zepp Health ROE %?

Zepp Health FRA:ST0 +1.09% 40 ROE % is -38.71% as of Mar. 2026. GuruFocus rates FRA:ST0 with a GF Score™ of 40/100 and a GF Value™ of €3.24 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 2,423 Hardware companies, Zepp Health ranks worse than 86.96% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Zepp Health's annualized net income for the quarter that ended in Mar. 2026 was €-68.0 Mil. Zepp Health's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was €175.6 Mil. Therefore, Zepp Health's annualized ROE % for the quarter that ended in Mar. 2026 was -38.71%.

The historical rank and industry rank for Zepp Health's ROE % or its related term are showing as below:

FRA:ST0' s ROE % Range Over the Past 10 Years
Min: -25.14   Med: 6.99   Max: 622.56
Current: -18.29

During the past 11 years, Zepp Health's highest ROE % was 622.56%. The lowest was -25.14%. And the median was 6.99%.

FRA:ST0's ROE % is ranked worse than
86.96% of 2423 companies
in the Hardware industry
Industry Median: 4.61 vs FRA:ST0: -18.29

Zepp Health  (FRA:ST0) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-67.964/175.583
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-67.964 / 178.352)*(178.352 / 471.5325)*(471.5325 / 175.583)
=Net Margin %*Asset Turnover*Equity Multiplier
=-38.11 %*0.3782*2.6855
=ROA %*Equity Multiplier
=-14.41 %*2.6855
=-38.71 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-67.964/175.583
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-67.964 / -65.704) * (-65.704 / -61.216) * (-61.216 / 178.352) * (178.352 / 471.5325) * (471.5325 / 175.583)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0344 * 1.0733 * -34.32 % * 0.3782 * 2.6855
=-38.71 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Zepp Health ROE % Related Terms


Zepp Health ROE % Historical Data

* Premium members only.

The historical data trend for Zepp Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zepp Health ROE % Chart

Zepp Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.11 -10.59 -8.28 -25.74 -16.16

Zepp Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.11 -13.09 -2.84 -19.93 -38.71

FRA:ST0 vs UEIC, AXIL, KOSS: ROE % Comparison

For the Consumer Electronics subindustry, Zepp Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zepp Health ROE % vs Hardware Industry

For the Hardware industry and Technology sector, Zepp Health's ROE % distribution charts can be found below:

* The bar in red indicates where Zepp Health's ROE % falls into.


FRA:ST0
40GF Score
Zepp Health Corp FRA:ST0
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zepp Health ROE % Calculation

Zepp Health's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-34.218/( (240.267+183.211)/ 2 )
=-34.218/211.739
=-16.16 %

Zepp Health's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-67.964/( (183.211+167.955)/ 2 )
=-67.964/175.583
=-38.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -38.71% mean?
Zepp Health (FRA:ST0) has a ROE % of -38.71% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #2107 out of 2423 companies in the Hardware industry, placing it in the top 87%.
Is Zepp Health's ROE % too high?
Zepp Health's current ROE % is -38.71%. Based on the distribution chart, Zepp Health ranks #2107 out of 2423 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Zepp Health has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's ROE % compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #2107 out of 2423 companies for ROE %. This places Zepp Health in the lower half of its industry. The industry median ROE % is 4.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Hardware company?
The median ROE % among Hardware companies is 4.61, based on 2,423 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Zepp Health and its competitors. For the Hardware industry, the median ROE % is 4.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current ROE % is -38.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.24, compared to a current price of €3.70 — trading 14.2% above its estimated fair value. The current ROE % is -38.71%. Zepp Health's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current ROE % is -38.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zepp Health (FRA:ST0) Overvalued in 2026?

Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued. The current stock price of €3.70 is trading 14.2% above its estimated GF Value™ of €3.24. GuruFocus considers Zepp Health to be Modestly Overvalued.

Key valuation signals for FRA:ST0:

  • ROE %: -38.71%
  • GF Value™: €3.24 vs. price of €3.70 (14.2% above fair value)
  • GF Score™: 40/100 with 2 warning signs

No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zepp Health Business Description

Other Exchanges ZEPP:USA
Address Edisonweg 44 - B08, Gorinchem, ZH, NLD, 4207 HG
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
40GF Score

Get the complete analysis for FRA:ST0

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.70
Price
€3.24
GF Value